EPCAM and hepatocellular carcinoma: By virtue of expressing EpCAM [20, 21], CTCs are predictive of poor outcome [25] and are preferentially involved in the formation of lung metastasis in breast cancer patients [26] as well as postsurgical recurrence in hepatocellular carcinoma (HCC) patients [27].